On September 30, Pilot Biotech announced the completion of 450 million yuan of pre-IPO financing. Old shareholders Yuanhe Holdings, Hunan Caixin, and Hunan Caixin continued to raise funds; new shareholders introduced a number of institutions such as Su Venture Capital, Su Industrial Investment, Yuanfeng Capital, and Maker Zhisheng. The funds raised this time will focus on new product development and industrialization implementation to increase market development efforts.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.